Bone Support

Share Price

  • Contact Us
Follow
  • US site
    • Global English Site
    • US site
    • Global Swedish Site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Sustainability
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT® G with Gentamicin
    • CERAMENT® BONE VOID FILLER
    • Delivery Devices for CERAMENT®
  • Innovation
    • Pipeline
    • CERTiFy Clinical Trial
  • Medical Professionals
    • TRAUMA: WHY USE CERAMENT®
    • BENIGN BONE TUMORS: WHY USE CERAMENT®
    • REVISION ARTHROPLASTY: WHY USE CERAMENT®
    • FOOT AND ANKLE: WHY USE CERAMENT®
    • CERAMENT® G Reimbursement
  • Investors
    • Financials
    • Financial Reports
    • Presentations
    • The Share
    • Shareholders
    • Analyst Coverage
    • Corporate Governance
    • Calendar
    • Q&A
    • Definitions
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Events
  • Media
    • Press Releases
    • Publications and Resources
    • Multimedia
  • Contact Us
  • Global English Site
  • US site
  • Global Swedish Site
  • Financials
  • Financial Reports
  • Presentations
  • The Share
  • Shareholders
  • Analyst Coverage
  • Corporate Governance
  • Calendar
  • Q&A
  • Definitions
  • CAPITAL MARKETS DAY 2022

Financial Reports 2019

BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017.

PDF Icon

Annual Report 2019

03/04/2020

PDF Icon

Full Year Report 2019

26/02/2020

Net sales increased with 100 percent compared to previous year, and amounted to SEK 46.2 million (23.1). Gross margin amounted to 88.9 percent (85.0). Operating profit amounted to SEK -38.6 million (-45.0).
PDF Icon

Interim Report, Q3, July - September 2019

07/11/2019

Net sales amounted to SEK 39.1 million (14.2), an increase of 175%. Gross margin amounted to 87.7% (81.8). Operating profit totaled SEK -32.7 million (-58.4).
PDF Icon

Interim Report, Q2, April - June 2019

25/07/2019

Net sales amounted to SEK 37.3 million (28.2), an increase of 32%. Gross margin amounted to 86.5% (87.4). Operating profit totaled SEK -47.8 million (-37.8).
PDF Icon

Interim Report, Q1, January - March 2019

02/05/2019

Net sales amounted to SEK 32.8 million (31.1), an increase of 6%. Gross margin of 85.9% (82.1). Operating profit totaled SEK -39.0 million (-33.1).

©BONESUPPORT AB 2023. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy